Symbol="DAWN"
AssetType="Common Stock"
Name="Day One Biopharmaceuticals Inc"
Description="Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and markets targeted therapies for patients with genetically defined cancers. The company is headquartered in South San Francisco, California."
CIK="1845337"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 OYSTER POINT BLVD STE 217, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1044708000"
EBITDA="-164952992"
PERatio="None"
PEGRatio="None"
BookValue="4.083"
DividendPerShare="0"
DividendYield="0"
EPS="-2.1"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.349"
ReturnOnEquityTTM="-0.56"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.1"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="40.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.153"
EVToRevenue="-"
EVToEBITDA="-9.02"
Beta="-2.077"
num_52WeekHigh="28.35"
num_52WeekLow="10.84"
num_50DayMovingAverage="13.03"
num_200DayMovingAverage="17.65"
SharesOutstanding="86842000"
DividendDate="None"
ExDividendDate="None"
symbol="DAWN"
open="12.00"
high="12.03"
low="11.49"
price="11.81"
volume="1216142.00"
latest_trading_day="2023-07-11"
previous_close="12.03"
change="-0.22"
change_percent="-1.8288%"
aroon_positive_momentum_days="19"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="1097791"
Change_recent_avg="-0.1"
Delta_recent_avg="0.91"
Variance_recent_avg="0.45"
Change_ratio_recent_avg="-0.75"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="496"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0109.jpeg"
image_negative_thumbnail_id_2="175"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="1012"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0174.jpeg"
image_positive_thumbnail_id_2="690"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0018.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
